A Rare Case of Rivaroxaban Causing Delayed Symptomatic Hepatocellular Injury and Hyperbilirubinemia
Importance. As Rivaroxaban has increased in popularity, it has been accompanied with a growing body of evidence displaying its ability to cause drug induced liver injury (DILI). Observation. A 74-year-old Caucasian female developed Rivaroxaban DILI two weeks after finishing a 14-day course. The pati...
Saved in:
Main Authors: | Keith Glenn, Patrick Chen, Mustafa Musleh, Rao Pallivi, Melissa Grilliot |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Gastrointestinal Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/5678187 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe Hyperbilirubinemia: A Rare Complication of Lyme Disease
by: Maarij Baig, et al.
Published: (2019-01-01) -
Hyperbilirubinemia: Does It Matter?
by: Lajos Okolicsanyi, et al.
Published: (1999-01-01) -
A rare case of Listeria monocytogenes bacteremia complicated by severe hyperbilirubinemia and liver failure
by: Yuan‐Ai Tseng, et al.
Published: (2025-01-01) -
A Rare Case of Spontaneous Cardiac Tamponade Induced by Concomitant Use of Rivaroxaban and Amiodarone
by: Oreoluwa Oladiran, et al.
Published: (2018-01-01) -
Rivaroxaban and Hemostasis in Emergency Care
by: Jürgen Koscielny, et al.
Published: (2014-01-01)